Injective rises 15% as price approaches key resistance at $4.09: weekly outlook

Traders Union
All News
Crypto
Injective advances 15.34% this week

Highlights

INJ remains under medium- and long-term selling pressure, trading below key moving averages and facing resistance at $3.72.
Momentum indicators reflect a mixed outlook, with strong downside signals and overbought conditions hinting at a possible short-term pullback.
Expected 7-day range is $3.11–$4.09, with a higher probability of downside consolidation than a bullish breakout.

Technical resistance persists as momentum and signals remain mixed

Weekly technicals show INJ sitting below key longer-term moving averages, with MA-20 at $3.72 acting as immediate dynamic resistance and MA-50 and MA-200 much higher up. Weekly support is anchored at $3.11, while resistance stands at $4.09. Momentum readings are mixed: the MACD and ADX highlight continued seller dominance and downside momentum, the RSI signals persistent weakness but not oversold, and the Stochastic RSI at 100 points to overbought territory, flagging risk of a pullback. CCI is neutral, Bull/Bear Power shows a minor buyer edge, yet the Awesome Oscillator offers no bullish confirmation.

Sideways bias expected as momentum signals limit breakout prospects

Looking ahead to the next 7 days, INJ is expected to consolidate within a range between $3.11 and $4.09. With none of the four key weekly indicators issuing Buy signals, the probability of a breakout above resistance is low, and a sideways or mild pullback scenario is favored. Should momentum fade, a move below $3.11 could accelerate selling pressure, while any push above $4.09 may attract follow-through buying and test higher resistance. The baseline expectation is for price action to calm, with short-term volatility likely to subside as the recovery stalls near resistance.

Viktoras Karapetjanc, expert at Traders Union, highlights Injective's strong weekly rebound, which has pushed price action to the top of its recent range but kept it below major moving averages. He sees last week's 15.34% gain as evidence of renewed interest, though he notes the broader trend is still shaped by seller pressure and mixed momentum readings. With week-ahead resistance at $4.09 and support at $3.11, Karapetjanc expects a consolidation phase, with potential for upside if market sentiment improves. He emphasizes that overbought signals suggest any further gains may require new catalysts. "I remain optimistic — this week presents opportunities if INJ can sustain above key supports, opening the way for renewed buyer momentum," he says.

Earlier, analysts noted that Injective was exhibiting short-term signs of recovery but remained weighed down by prevailing medium- and long-term bearish momentum. The latest data reinforces this cautious view, with sustained resistance overhead suggesting that traders should closely monitor the $4.09 level as a potential pivot for near-term sentiment shifts.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.